Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Envision Analogue – An Introduction

    June 18, 2024 | Cancer, EMA, Envision, FDA, HTA, Market Access, analogue, oncology 

    Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive EMA or FDA guidance.

    tijana being interviewed

    This content was provided by Genesis Research Group

    Company Details

    Genesis Research Group logo

    Genesis Research Group

    Email
    Website

     Latest Content from  Genesis Research Group 

    Genesis Research Acquires Market Access Transformation

    Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

    ISPOR 2022: a retrospective

    Genesis Research – an introduction

    Ensuring fit-for-purpose real-world data to generate real-world evidence with Susan Oliveria

    Genesis Research at the World EPA Congress 2022

    GHO Capital Acquires Genesis Research

    GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

    Genesis Research: What is EVID AI?

    Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches

    What is EVID AI?